The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Endocrinology,Biochemistry
Reference88 articles.
1. Sphingolipids and lysosomal pathologies;Schulze;Biochim. Biophys. Acta.,2013
2. The cell biology of lysosomal storage disorders;Futerman;Nat. Rev. Mol. Cell Biol.,2004
3. Prevalence of lysosomal storage disorders;Meikle;JAMA.,1999
4. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis;Sandhoff;J. Neurosci.,2013
5. The cellular pathology of lysosomal diseases;Cox;J. Pathol.,2012
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09
2. A comprehensive measure of Golgi sphingolipid flux using NBD C6-ceramide: evaluation of sphingolipid inhibitors;Journal of Lipid Research;2024-08
3. Gaucher Disease: A Glance from a Medicinal Chemistry Perspective;ChemMedChem;2024-03-08
4. Targeting MHC-I inhibitory pathways for cancer immunotherapy;Trends in Immunology;2024-03
5. Phase 1 Healthy Volunteer Study of AL01211, an Oral, Non‐brain Penetrant Glucosylceramide Synthase Inhibitor, to Treat Fabry Disease and Type 1 Gaucher Disease;Clinical Pharmacology in Drug Development;2024-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3